Titelia

Holdings of SUPERSTRING CAPITAL MANAGEMENT LP

32 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 62.2 % of the equity sleeve

Sector breakdown

  • Health care 11.5 %
  • Unattributed 88.5 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 89.4 %
  • KY 6.4 %
  • DK 4.2 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1US29112.1M $89.36 %
2KY28.1M $6.43 %
3DK15.3M $4.21 %

Positions

RankCompanySharesValueWeight
1Summit Therapeutics Inc 892,87316.9M $
2Immunovant Inc 357,6068.9M $
3Cogent Biosciences Inc 225,1588.7M $
4Savara Inc 1,585,9778.7M $
5Vir Biotechnology Inc 730,5486.5M $
6Vaxcyte Inc 110,4546.4M $
7Celldex Therapeutics Inc 180,0485.7M $
8Sionna Therapeutics Inc 141,0245.7M $
9Genmab A/S 196,7095.3M $
10ZAI LAB LTD 275,8185.2M $
11Vertex Pharmaceuticals Inc 11,0104.9M $
12IQVIA Holdings Inc 25,6684.4M $
13MapLight Therapeutics Inc 192,1393.9M $
14Arvinas Inc 312,6203.3M $
15Oruka Therapeutics Inc 63,5913.1M $
16United Therapeutics Corp 5,1863.1M $
17Travere Therapeutics Inc 102,7543.1M $
18Trevi Therapeutics Inc 251,5663M $
19Adlai Nortye Ltd. 414,8522.9M $
20Cabaletta Bio Inc 1,066,2392.9M $
21Pfizer Inc 74,0002.1M $
22Axsome Therapeutics Inc 11,2171.9M $
23ORIC Pharmaceuticals Inc 115,2341.5M $
24Aclaris Therapeutics Inc 366,4901.4M $
25Climb Bio Inc 199,2091.4M $
26Taysha Gene Therapies Inc 258,2691.2M $
27Tonix Pharmaceuticals Holding Corp 63,540873.7K $
28Cullinan Therapeutics Inc 59,484845.3K $
29Protara Therapeutics Inc 121,457632.8K $
30PALATIN TECHNOLOGIES INC 35,969626.6K $
31BIOMEA FUSION INC 250,000382.5K $
32Century Therapeutics Inc 119,308269.6K $